Improving HIV Care With Telehealth
Published 01-26-22
Submitted by Gilead Sciences
Originally published by Gilead Sciences
Telehealth has transformed HIV service delivery during the COVID-19 pandemic. But as a new Gilead policy paper explains, it’s critical that telehealth programs are designed to promote health equity and include all populations, including low-income individuals, people in non-urban areas with less technology access and older populations with low technology or health literacy. Learn more. https://gilead.inc/3qS2c0p
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Gilead Sciences
Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
More from Gilead Sciences